GreenMark Biomedical Patents – Insights & Stats (Updated 2023)

GreenMark Biomedical has a total of 34 patents globally, out of which 9 have been granted. Of these 34 patents, more than 64% patents are active. The United States of America is where GreenMark Biomedical has filed the maximum number of patents, followed by Canada. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of GreenMark Biomedical.

GreenMark Biomedical was founded in 2016. GreenMark Biomedical is a health care company. It creates technologies using tiny biopolymer particles made from starch intended for food use. The company’s diagnostic device is used by dental practitioners as part of a standard dental exam to assess and monitor non-invasive treatment of dental caries.

Do read about some of the most popular patents of GreenMark Biomedical which have been covered by us in this article and also you can find GreenMark Biomedical patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over GreenMark Biomedical patent portfolio.

How many patents does GreenMark Biomedical have?

GreenMark Biomedical has a total of 34 patents globally. These patents belong to 8 unique patent families. Out of 34 patents, 22 patents are active.

How Many Patents did GreenMark Biomedical File Every Year?

GreenMark Biomedical Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantGreenMark Biomedical Applications FiledGreenMark Biomedical Patents Granted

How many GreenMark Biomedical patents are Alive/Dead?

Worldwide Patents

GreenMark Biomedical Patent Portfolio

How Many Patents did GreenMark Biomedical File in Different Countries?

GreenMark Biomedical Worldwide Patent Fiing

Countries in which GreenMark Biomedical Filed Patents

United States Of America14

Where are Research Centers of GreenMark Biomedical Patents Located?

The Research Centers of GreenMark Biomedical Patents is the United States of America.

10 Best GreenMark Biomedical Patents

US20120141551A1 is the most popular patent in the GreenMark Biomedical portfolio. It has received 13 citations so far from company like Ecosynthetix, Mcafee.

Below is the list of 10 most cited patents of GreenMark Biomedical:

Publication NumberCitation Count

What Percentage of GreenMark Biomedical US Patent Applications Were Granted?

GreenMark Biomedical (Excluding its subsidiaries) has filed 8 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 2 have been granted leading to a grant rate of 33.33%.

Below are the key stats of GreenMark Biomedical patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for GreenMark Biomedical?

Law FirmTotal ApplicationsSuccess Rate
Borden Ladner Gervais Llp833.33%

List of GreenMark Biomedical patents

GreenMark Biomedical PatentsTitle
US20120141551A1Phosphate Crosslinked Starch Nanoparticle And Dental Treatments
US10285943B2Aptamer Bioconjugate Drug Delivery Device
US20190339279A1Aptamer Bioconjugate Drug Delivery Device
US20190298660A1Phosphate Crosslinked Starch Nanoparticle And Dental Treatments
US20130090467A1Bisphosphonate Loaded Starch Nanoparticle
US20210321864A1Humectant And/Or Buffered Starch Compositions And Use In Oral Care Such As Treating Xerostomia
US20210169403A1Aptamer Bioconjugate Drug Delivery Device
WO2020051352A1Dental Imaging And/Or Curing System
US11369570B2Aptamer Bioconjugate Drug Delivery Device
US11666515B2Drug Delivery Device For An Aptamer Bioconjugate
US20230277423A1Dental Imaging And/Or Curing System
US20220370372A1Phosphate Crosslinked Starch Nanoparticle And Dental Treatments
US20220288116A1Aptamer Bioconjugate Drug Delivery Device
US20210338585A1Dental Imaging System And Image Analysis
EP2645991B1Phosphate Crosslinked Starch Nanoparticle And Dental Treatments
DE602011065006T2Aptamer Bioconjugate Drug Delivery Device
EP3847442A4Aptamer Bioconjugate Drug Delivery Device
EP3773751A4Aptamer Bioconjugate Drug Delivery Device
CA2819240CDental Imaging System And Image Analysis
CA3210287A1Aptamer Bioconjugate Drug Delivery System
CA3090303A1Phosphate-Crosslinked Starch Nanoparticles And Dental Treatment
CA2790763A1Methods For Manufacturing Nanoparticles, For Treatment Of Teeth, And For Manufacturing A Biopolymer Nanoparticle, Nanoparticles, Use Of The Nanoparticles, Starch Nanoparticle Cross-Cutted With Polyphosphate, And, Use Of A Starch Nanoparticle Cross-Cutted With Polyphosphate.
AU2012318273B2Method Of Detecting Cracks In Teeth
AU2011336352B2Aptamer Bioconjugate Drug Delivery Device
AU2022229909A1Detecting Nitroaromatic Compounds With Pyrene-Labeled Starch Nanoparticles
JP6035633B2Phosphate-Crosslinked Starch Nanoparticles And Use For Drug Delivery
JP2021519310AAptamer Bioconjugate Drug Delivery Device
BR112020016701A2Aptamer Bioconjugate Drug Delivery Device
US20190374469A1Arzneimittelabgabevorrichtung Für Ein Aptamer-Biokonjugat
AT1231177TDental Imaging System And Image Analysis
WO2022187654A1Humectant And/Or Buffered Starch Compositions And Use In Oral Care Such As Treating Xerostomia
WO2021102095A1Bisphosphonate Loaded Starch Nanoparticle
WO2021062204A1Dental Imaging And/Or Curing System
WO2019191456A1Phosphate Crosslinked Starch Nanoparticle And Dental Treatments

What are GreenMark Biomedical key innovation segments?

What Technologies are Covered by GreenMark Biomedical?

The chart below distributes patents filed by GreenMark Biomedical in different countries on the basis of the technology protected in patents. It also represents the markets where GreenMark Biomedical thinks it’s important to protect particular technology inventions.

R&D Focus: How has GreenMark Biomedical search focus changed over the years?


Interested in knowing about the areas of innovation that are being protected by GreenMark Biomedical?

Related Articles

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.